Millions across the world are struggling to lose weight and keep it off. In many cases, the struggle is not due to lack of effort or commitment. Science has shown that obesity is not a problem that must be overcome solely by your own willpower— the gut may play a large role in preventing the weight loss you are looking for. Fortunately, there is a way to address this barrier with a medication called Semaglutide.

What is Semaglutide?

Semaglutide, also known as (Wegovy™) is a prescription medication for long-term weight management. It is an FDA-approved once-weekly injection that helps with weight loss when used in combination with a reduced-calorie diet and increased physical activity.

Several studies have shown significant weight loss for patients on Semaglutide.

The largest clinical trial showed an average weight loss of 35lb (a 14.9% reduction from initial body weight) for people who used Semaglutide.This was five times greater weight loss than those who completed diet and exercise alone.

How Does Semaglutide Work?

Semaglutide mimics a hormone called glucagon-like peptide-1 (GLP-1), which sends the “I’m full” signal to the brain. It does this by slowing gastric emptying, which promotes satiety. In other words, it helps you feel full earlier and stay full longer. Glycemic control and insulin sensitivity also improve, helping to promote fat loss while reducing cravings.

Am I a Candidate?

Semaglutide is an office-administered weekly subcutaneous injection in either the upper arm, stomach, or thigh. Your wellness and weight loss specialist will discuss scheduling, dosing protocol, and rotation of injection sites.

Semaglutide is a prescription drug and is administered only after reviewing a candidate’s medical and family history with the completion of a physical exam to determine eligibility.

Candidates include adults with a BMI over 30 kg/m or a BMI of 27 kg/m with risk factors such as diabetes, hypertension or dyslipidemia.

All candidates are screened for various health conditions to determine eligibility. Patients who are pregnant, nursing, or plan to become pregnant may not be candidates for Contrave. Also patients with a history of any of the following may not be candidates:

  • Diabetes with history of diabetic retinopathy
  • Personal or family history of thyroid cancer, multiple endocrine neoplasia 2A or 2B
  • Pancreatitis or kidney disease
  • Depression, suicidal thoughts, or mental health issues

Most people tolerate Semaglutide well without significant side effects. The most commonly reported side effects include gastrointestinal effects such as abdominal discomfort, nausea, vomiting, constipation, diarrhea, feeling bloated and gas. Other side effects include but are not limited to: tiredness, dizziness, headache, pancreatitis,and heartburn.

If you have any questions, please reach out to your Wellness Specialist at 813-345-4044.